Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

CVS Caremark and Express Scripts, along with GoodRx and others, are accused of working together to suppress reimbursements to independent pharmacies in at least three class-action lawsuits. Also, Hims ...

Hims & Hers (HIMS) is down -14.6%, or -$3.25 to $19.00. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks ...

Fatty liver disease happens when fat builds up in your liver. This can cause damage, inflammation, and other complications.

Hims & Hers Health, Inc. HIMS is scheduled to report third-quarter 2024 results on Nov. 4, after the closing bell. In the last reported quarter, the company’s earnings per share (EPS) of 6 cents ...

Whoever wins the presidency, the 2024 election has outsized implications for California. The elevation of Democratic Vice President Kamala Harris to the highest office in the land would make her the ...

1 Day HIMS -1.10% DJIA -0.90% S&P 500 -1.86% Retail/Wholesale -0.53% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Hims & Hers currently offers compounded GLP-1 weight-loss injections at $199 per month and weight management oral medication ...